Related Experiment Video
Updated: Jun 24, 2026
10:16
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
True Gaucher's Disease or Pseudo-Gaucher Presentations.
1Department of Clinical Laboratory, The First Hospital of Qinhuangdao, Qinhuangdao, China.
Summary
A rare thalassemia complication caused pseudo-Gaucher cells, mimicking Gaucher disease. Normal enzyme tests excluded Gaucher disease, highlighting the need for careful diagnosis.
Area of Science:
- Hematology
- Genetic Blood Disorders
- Cellular Pathology
Background:
- Alpha-thalassemia is a genetic blood disorder.
- Gaucher disease is a lysosomal storage disorder.
- Histiocytic proliferation can occur in various conditions.
Purpose of the Study:
- To report a rare case of pseudo-Gaucher cells in alpha-thalassemia.
- To emphasize the importance of differentiating reactive histiocytosis from storage disorders.
Main Methods:
- Bone marrow examination was performed.
- Histopathological analysis revealed pseudo-Gaucher histiocytes.
- Enzyme activity assays were conducted to exclude Gaucher disease.
Main Results:
- Extensive sheets of pseudo-Gaucher histiocytes were observed in a patient with alpha-thalassemia.
- Normal enzyme activity confirmed the absence of true Gaucher disease.
- The findings suggest a reactive histiocytic proliferation.
Conclusions:
- Alpha-thalassemia can present with prominent histiocytic proliferation mimicking Gaucher disease.
- Comprehensive diagnostic evaluation is crucial to distinguish reactive histiocytosis from storage disorders.
- This case underscores the variability of hematological manifestations in thalassemia.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...